ArticleNature communications2026
RAISE: A computational tool for evaluating sarbecovirus spillover potential.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Animal sarbecoviruses, relatives of SARS-CoV or SARS-CoV-2, pose a significant zoonotic threat driven by their ability to bind the human ACE2 (hACE2) receptor. To address challenges in evaluating these threats, we developed RAISE (Receptor binding domain-hACE2 Interaction Scoring Evaluation), a computational framework that integrates structural predictions with interaction scoring. By scoring predicted hACE2 interactions, our RAISE model categorized sarbecoviruses into three groups: high potential (hACE2-binding), negligible potential (hACE2-nonbinding), and an intermediate "poised" state (a state defined by either weak binding activity or a high potential to evolve it). Mutation screening of two "hACE2-poised" sarbecoviruses, PDF-2370 and Khosta-1 using RAISE, revealed mutations such as T498Y/W that enabled human ACE2 utilization and expanded their ability to bind to ACE2 receptors from a broader range of species. The model's generalizability was further demonstrated through prospective application to merbecoviruses, highlighting its utility in preemptively assessing zoonotic threats across coronavirus lineages. RAISE provides a predictive roadmap for prioritizing risk viruses and guiding pandemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.